Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Protalix BioTherapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q1 2022
- Shares held
- 1.19M
- +17.1K (+1.5%) vs. Q1 2022
- Total value
- $1.30M
- +$53.4K (+4.3%) vs. Q1 2022
- New holders
- 4
- 6 more added
- Sold out
- 5
- 7 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $30.9M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $11.9M |
| Q4 2023 | 66 | $17.6M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.45M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.24M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 395 | $0 | 0.00% | −732−65.0% | Reduced |
| Royal Bank of Canada | 15 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 120 | $0 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 250 | $273 | 0.00% | −850−77.3% | Reduced |
| American Portfolios Advisors | 500 | $545 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ten Capital Wealth Advisors, LLC | 790 | $1.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,504 | $4.00K | 0.00% | −1,649−32.0% | Reduced |
| Federated Hermes, Inc. | 5,761 | $6.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6,000 | $6.48K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6,100 | $7.00K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,217 | $9.00K | 0.00% | −15,700−65.6% | Reduced |
| Smith, Salley & Associates | 12,048 | $13.0K | 0.00% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 12,418 | $14.0K | 0.00% | +967+8.4% | Added |
| Millennium Management LLC | 19,223 | $21.0K | 0.00% | +19,223 | New |
| IHT Wealth Management, LLC | 22,000 | $24.0K | 0.00% | −2,000−8.3% | Reduced |
| Davenport & Co LLC | 22,000 | $24.0K | 0.00% | +10,000+83.3% | Added |
| Two Sigma Investments, LP | 25,510 | $28.0K | 0.00% | +25,510 | New |
| Capital Performance Advisors LLP | 25,974 | $28.0K | 0.02% | +25,974 | New |
| Virtu Financial LLC | 28,816 | $31.0K | 0.00% | +13,617+89.6% | Added |
| Citadel Advisors LLC | 59,915 | $65.0K | 0.00% | +59,915 | New |
| Two Sigma Advisers, LP | 73,671 | $80.0K | 0.00% | +14,771+25.1% | Added |
| Jane Street Group, LLC | 83,556 | $91.0K | 0.00% | −61,652−42.5% | Reduced |
| BlackRock Inc. | 101,553 | $111.0K | 0.00% | −7,508−6.9% | Reduced |
| Renaissance Technologies LLC | 114,800 | $125.0K | 0.00% | +102,900+864.7% | Added |
| Spire Wealth Management | 148,800 | $162.0K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 158,790 | $173.0K | 0.00% | +130,000+451.5% | Added |
| Meitav Dash Investments Ltd | 244,332 | $264.0K | 0.00% | 00.0% | Unchanged |
| Phoenix Holdings Ltd. | 0 | $0 | 0.00% | −244,113−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −32,646−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,119−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −6,465−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |